Search research articles
Contact Us
Filters
Showing results (11-20 of 27) with videos related to
Page
of 3
Sort By:
Acta Psychiatrica Scandinavica
|
November 4, 2004
The potential relationship between levels of perceived stress and subtypes of major depressive disorder (MDD)
A H Farabaugh, D Mischoulon, M Fava, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists
|
June 14, 2011
Effects of S-adenosylmethionine augmentation of serotonin-reuptake inhibitor antidepressants on cognitive symptoms of major depressive disorder
Y Levkovitz, J E Alpert, C E Brintz, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists
|
March 15, 2011
SAMe and sexual functioning
C M Dording, D Mischoulon, I Shyu, et al.
Brain, Behavior, and Immunity
|
April 22, 2022
Interleukin-6 receptor antagonists in immunopsychiatry: Can they lead to increased interleukin-6 in the central nervous system (CNS) and worsening psychiatric symptoms?
N Mac Giollabhui, S Foster, C A Lowry, et al.
Journal of Cellular Physiology
|
November 1, 1992
Differential regulation of glucose transporter 1 and 2 mRNA expression by epidermal growth factor and transforming growth factor-beta in rat hepatocytes
D Mischoulon, B Rana, N Kotliar, et al.
Journal of Psychosomatic Research
|
December 9, 2000
Anemia and macrocytosis in the prediction of serum folate and vitamin B12 status, and treatment outcome in major depression
D Mischoulon, J K Burger, M K Spillmann, et al.
Acta Psychiatrica Scandinavica
|
November 18, 2003
Clinical and sociodemographic predictors of response to augmentation, or dose increase among depressed outpatients resistant to fluoxetine 20 mg/day
R H Perlis, J Alpert, A A Nierenberg, et al.
Molecular Psychiatry
|
March 25, 2015
Inflammation as a predictive biomarker for response to omega-3 fatty acids in major depressive disorder: a proof-of-concept study
M H Rapaport, A A Nierenberg, P J Schettler, et al.
Psychotherapy and Psychosomatics
|
March 13, 2001
Management of major depression in the primary care setting
D Mischoulon, R McColl-Vuolo, S Howarth, et al.
Molecular Psychiatry
|
July 25, 2012
Are omega-3 fatty acids antidepressants or just mood-improving agents? The effect depends upon diagnosis, supplement preparation, and severity of depression
P-Y Lin, D Mischoulon, M P Freeman, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 27) with videos related to
Sort By:
Page
of 3
Acta Psychiatrica Scandinavica
|
November 4, 2004
The potential relationship between levels of perceived stress and subtypes of major depressive disorder (MDD)
A H Farabaugh, D Mischoulon, M Fava, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists
|
June 14, 2011
Effects of S-adenosylmethionine augmentation of serotonin-reuptake inhibitor antidepressants on cognitive symptoms of major depressive disorder
Y Levkovitz, J E Alpert, C E Brintz, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists
|
March 15, 2011
SAMe and sexual functioning
C M Dording, D Mischoulon, I Shyu, et al.
Brain, Behavior, and Immunity
|
April 22, 2022
Interleukin-6 receptor antagonists in immunopsychiatry: Can they lead to increased interleukin-6 in the central nervous system (CNS) and worsening psychiatric symptoms?
N Mac Giollabhui, S Foster, C A Lowry, et al.
Journal of Cellular Physiology
|
November 1, 1992
Differential regulation of glucose transporter 1 and 2 mRNA expression by epidermal growth factor and transforming growth factor-beta in rat hepatocytes
D Mischoulon, B Rana, N Kotliar, et al.
Journal of Psychosomatic Research
|
December 9, 2000
Anemia and macrocytosis in the prediction of serum folate and vitamin B12 status, and treatment outcome in major depression
D Mischoulon, J K Burger, M K Spillmann, et al.
Acta Psychiatrica Scandinavica
|
November 18, 2003
Clinical and sociodemographic predictors of response to augmentation, or dose increase among depressed outpatients resistant to fluoxetine 20 mg/day
R H Perlis, J Alpert, A A Nierenberg, et al.
Molecular Psychiatry
|
March 25, 2015
Inflammation as a predictive biomarker for response to omega-3 fatty acids in major depressive disorder: a proof-of-concept study
M H Rapaport, A A Nierenberg, P J Schettler, et al.
Psychotherapy and Psychosomatics
|
March 13, 2001
Management of major depression in the primary care setting
D Mischoulon, R McColl-Vuolo, S Howarth, et al.
Molecular Psychiatry
|
July 25, 2012
Are omega-3 fatty acids antidepressants or just mood-improving agents? The effect depends upon diagnosis, supplement preparation, and severity of depression
P-Y Lin, D Mischoulon, M P Freeman, et al.
Page
of 3